Day 3 Full Agenda
Wednesday, May 6, 2026
8:30 AM
Promising Biomarkers for PTE
Introduction: Firas Kobaissy (University of Florida), Session Moderator
| "Vascular Health as a target in diagnosis and prevention of post-traumatic epilepsy" | Alon Friedman, MD, PhD, Dalhousie University |
| "Blood based protein biomarker signatures of PTE development; clinical and preclinical studies" | Denes Agoston, MD, PhD, Uniformed Services University |
| "Dysregulated Inflammation as a Predictor and Potential Therapeutic Target in Post-Traumatic Epilepsy" | Edward Needham, MBBS, PhD, University of Cambridge |
| "Gut-microbiota-brain axis and post-traumatic epilepsy" | Andrey M. Mazarati, MD, PhD, FAES, University of California, Los Angeles |
10:00 AM - Break
10:15 AM
Promising Pharmacologic and Non-Pharmacologic Therapies for PTE
Introduction: Lisa Coles (University of Minnesota), Session Moderator
| "2024-2026: The vagaries of clinical development of PTE preventive treatment" | Pavel Klein, MD, PrevEp, Inc./Mid-Atlantic Epilepsy and Sleep Center |
| "Changes in synaptic vesicle glycoprotein 2A (SV2A)expression and localisation during epilepsy" | Jens D. Mikkelsen, MD, PhD, University of Copenhagen |
| Announced April 1st | Early-Stage Investigator |
11:25 AM
Discussion and Wrap-up: How will we prioritize therapies for early Phase Clinical Trials?
Moderator and Discussants: Ramon Diaz-Arrastia, Pavel Klein
12:15 PM